Citation International journal of urology (2. Right which has been published in final f

Similar documents
GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

EUROPEAN UROLOGY 60 (2011)

A patient with recurrent bladder cancer presents with the following history:

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer

Upper Tract Tcc. Mohan Arianayagam FRACS (Urology)

BLADDER CANCER: PATIENT INFORMATION

Which is best method for instillation of topical therapy to the upper urinary tract? An in vivo porcine study to evaluate three delivery methods

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma

Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer

Radical Cystectomy Often Too Late? Yes, But...

Clinical Study Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour Free Status Be Achieved?

Bladder Cancer Guidelines

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

EAU GUIDELINES ON NON-MUSCLE INVASIVE (TaT1, CIS) BLADDER CANCER

Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer

Bladder Cancer Canada November 21st, Bladder Cancer 2018: A brighter light at the end of the cystoscope

ENDOSCOPIC URETERECTOMY DURING NEPHROURETERECTOMY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA

Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma

NMIBC. Piotr Jarzemski. Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland

Beware the BCG Failures: A Review of One Institution's Results

Case Report Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports

Issues in the Management of High Risk Superficial Bladder Cancer

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Haematuria and Bladder Cancer

MEDitorial March Bladder Cancer

Management of High Grade, T1 Bladder Cancer Douglas S. Scherr, M.D.

90% of bladder tumours are transitional cell carcinoma (TCC), the remaining 10% of cases are squamous cell carcinoma, adenocarcinoma and sarcoma.

Attachment #2 Overview of Follow-up

The Clinical Impact of the Classification of Carcinoma In Situ on Tumor Recurrence and their Clinical Course in Patients with Bladder Tumor

3.1 Investigations for Patients Presenting with Haematuria Table 1

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

IMAGING OF UPPER UT TCC

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Bladder cancer - suspected

INTRAVESICAL THERAPY AND FOLLOW-UP OF SUPERFICIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Current Experience with Intrapelvic/Intraureteral Irrigation/Ablative Therapy

The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette Guérin in Superficial Bladder Cancer: a Preliminary Study

Attachment #2 Overview of Follow-up

European Association of Urology. Pocket Guidelines edition

Carcinoma of the Renal Pelvis and Ureter Histopathology

Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto

Staging and Grading Last Updated Friday, 14 November 2008

Management of Superficial Bladder Cancer Douglas S. Scherr, M.D.

Organ-sparing treatment of invasive transitional cell bladder carcinoma

Original Article APMC-276

Atumor in a duplicated urinary tract is very infrequent.

Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience

Urothelial carcinomas of the upper urinary tract how does UK practice compare with European guidelines: is there a difference?

Maintenance Therapy with Intravesical Bacillus Calmette Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive

Controversies in the management of Non-muscle invasive bladder cancer

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules

Upper Tract Urothelial Cancers Nephron Sparing Strategies

Case by Case: Critical Issues in Superficial Bladder Cancer Management 5/24/05 13:46 1

SUPERFICIAL BLADDER CANCER MANAGEMENT

Guidelines on Non-muscle invasive Bladder Cancer (TaT1 and CIS)

UNDERSTANDING BLADDER CANCER

Ureteroscopic Treatment of Upper Tract Neoplasms

Contents of Online Supporting Information. etable 1. Study characteristics for trials of intravesical therapy vs. TURBT alone

Majid Eshghi, MD, FACS, MBA Valhalla, New York January 2018

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer

Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes

Carcinoma of the Urinary Bladder Histopathology

BLADDER CANCER CONTENT CREATED BY. Learn more at

3. Urinary Catheters. Indications. Methods of Bladder Catheterization. Hashim Hashim

Effectiveness of A Single Immediate Mitomycin C Instillation in Patients with Low Risk Superficial Bladder Cancer: Short and Long-Term Follow-up

UROTHELIAL CELL CANCER

Non-Muscle Invasive Bladder Cancer BCG Failures: University of Iowa Hospitals and Clinics Experience. Paul Gellhaus Assistant Clinical Professor

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds

Protocol for BCG + maintenance, Donald L. Lamm, MD Last Updated Friday, 14 November 2008

Non Muscle Invasive Bladder Cancer. Primary and Recurrent TCC 4/10/2010. Two major consequences: Strategies: High-Risk NMI TCC

Guidelines for the Management of Bladder Cancer

Costing report: Bladder cancer

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer ANewAnalysis

Radiochemotherapy after Transurethral Resection is an Effective Treatment Method in T1G3 Bladder Cancer


GUIDELINES FOR THE MANAGEMENT OF BLADDER CANCER

Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma

Glossary of Terms Primary Urethral Cancer

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

ENDOSCOPIC MANAGEMENT OF A URETERAL OBSTRUCTION CAUSED BY ENDOMETRIOSIS: A CASE REPORT

Evaluation, management and outcome of upper urinary tract transitional cell carcinoma A five year single center experience

UROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT

Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer

Original Article Squamous cell carcinoma in a duplicated renal pelvis

Bladder Case # 1. Principal Diagnosis: Bladder Tumor, Suspect Transitional Cell Carcinoma. Secondary Diagnoses: 1. Hypertension. 2. Hyperlipidemia.

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by

Diagnosis and classification

Renal tumors of adults

Afterword: The Paris System for Reporting Urinary Cytology

Transitional Cell Carcinoma of the Upper Ureter Metastatic to the Thoracic Spine Presenting as a Spinal Cord Compression

Symptoms, Diagnosis and Classification

Title high grade malignancy: report of a. Takeuchi, Hideo; Konami, Teruo; Tak Tomoyoshi, Tadao; Yoshitomi, Joji

How do I prepare for treatment? What happens afterwards? Where can I get more information? Cancerbackup The Prostate Cancer Charity

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

Robotic Surgery for Upper Tract Urothelial Carcinoma. Li-Ming Su, MD

Transcription:

Title Novel constant-pressure irrigation of renal pelvic tumors after ipsila Nakamura, Kenji; Terada, Naoki; Sug Author(s) Toshinori; Matsui, Yoshiyuki; Imamu Kazutoshi; Kamba, Tomomi; Yoshimura Citation International journal of urology (2 Issue Date 2014-06 URL http://hdl.handle.net/2433/199612 This is the peer reviewed version o Nakamura, K., Terada, N., Sugino, Y Y., Imamura, M., Okubo, K., Kamba, Ogawa, O. (2014), Novel constant-pr Right for the treatment of renal pelvic t ureterectomy. International Journal which has been published in final f http://dx.doi.org/10.1111/iju.12386 for non-commercial purposes in acco and Conditions for Self-Archiving. Type Journal Article Textversion author Kyoto University

A novel constant-pressure irrigation technique for the treatment of renal pelvic tumors after ipsilateral ureterectomy Kenji Nakamura, Naoki Terada, Yoshio Sugino, Toshinori Yamasaki, Yoshiyuki Matsui, Masaaki Imamura, Kazutoshi Okubo, Tomomi Kamba, Koji Yoshimura, Osamu Ogawa Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan Author for correspondence and reprint requests: Osamu Ogawa MD,PhD. Department of Urology, Kyoto University Graduate School of Medicine 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, Japan Phone: +81-75-751-3337 Fax: +81-75-751-3740 E-mail: kenji924@kuhp.kyoto-u.ac.jp Running title: Constant-pressure irrigation technique Abbreviations: CIS = carcinoma in situ CECT = contrast-enhanced computed tomography Key words Pelvic Neoplasms; Instillation, Drug; Nephrostomy, Percutaneous; Mitomycin

Abstract We herein report a case of a renal pelvic tumor that developed in the residual left renal pelvis after right nephroureterectomy, left ureterectomy, and total cystectomy in a patient with multiple urothelial tumors. The tumor was endoscopically ablated via a nephrostomy tract, and mitomycin C irrigation was performed. We designed a novel constant-pressure irrigation system for effective and safe irrigation into the closed space of the renal pelvis. We created a hole in the urine bag tube, inserted a 5-F open-end ureteral catheter via the hole, and kept the tip of the catheter at the end of the nephrostomy tube. The urine bag tube was placed 20 cm above the kidney level, and mitomycin C was continuously irrigated into the renal pelvis for 1 hour. Six weekly treatments were performed, and tumor recurrence was not identified for 1 year. Introduction Nephroureterectomy with open excision of the bladder cuff remains the gold standard treatment for upper urinary tract urothelial carcinoma 1. However, because of concerns about preservation of renal function or the inability of

patients to tolerate surgery, a select group of patients may be suitable for organ-preserving treatment. We herein present a novel constant-pressure irrigation technique. Because this irrigation system would allow for the increased performance of organ-preserving treatment, general urologists will find this manuscript very useful. Methods A 63-year-old man had undergone four transurethral resections for the treatment of superficial bladder tumors from 2007 to 2009. Histological examinations revealed grade 2 pt1 tumors together with carcinoma in situ (CIS). He didn t have any risk factors of multifocal urothelial carcinoma, such as smoking. In 2009, right renal pelvic tumors, left lower ureteral tumors, and bladder CIS were found by contrast-enhanced computed tomography (CECT) and cystoscopy. Total cystectomy and bilateral nephroureterectomy were recommended. However, the patient refused this treatment option because of his strong desire to avoid hemodialysis. Therefore, right nephroureterectomy, left ureterectomy, total cystectomy, and

left nephrostomy were performed. Histological examination revealed grade 2 pt3 papillary urothelial carcinoma in the right renal pelvis and grade 2 pta/is papillary urothelial carcinoma in the left ureter and the bladder, and combination chemotherapy using methotrexate, epirubicin, and cisplatin was performed. After 2 years of follow-up, the patient s urinary cytology result was positive, and a solitary left renal pelvic tumor was found by CECT. The tumor was endoscopically ablated using a 22-F flexible cystoscope. Histological examination revealed grade 2 pta papillary urothelial carcinoma. A 22-F nephrostomy tube was inserted after the surgery, and adjuvant mitomycin C irrigation into the residual renal pelvis via the nephrostomy tube was scheduled. Because the renal pelvis was a closed space after the ipsilateral ureterectomy, an irrigation catheter was essential for safe and effective treatment. However, to our knowledge, no appropriate catheter is available, such as a three-way Foley catheter for bladder irrigation. Therefore, we created a novel constant-pressure irrigation system using a nephrostomy catheter, urine bag, and open-end ureteral catheter (Figure 1). Our technique for mitomycin C irrigation was performed with the patient in

the supine position. A small hole was made in the middle of the urine bag tube, and a 5-Fr open-end ureteral catheter was inserted into the hole. Using the fluoroscope, the tip of the ureteral catheter was kept at the end of the nephrostomy catheter. At first, contrast media was irrigated at 100 ml/h, and we fluoroscopically confirmed that the renal pelvis was perfused by the contrast media. To maintain a constant pressure in the renal pelvis, the distance between the kidney and the urine bag tube was kept at 20 cm. Under these conditions, renal pelvic irrigation was performed using mitomycin C. A bottle of 40 mg mitomycin C dissolved in 100 ml of 0.9% saline was irrigated via the ureteral catheter for 1 hour (Figure 2). Six weekly treatments were performed. The serum creatinine concentration was 1.3 to 1.5 mg/dl during the treatment period and 1.3 mg/dl 1 year after treatment. One year after the treatment, no recurrence or metastasis was identified. Discussion Instillation therapy can be accomplished in several ways. Accepted techniques include antegrade instillation through a nephrostomy tube 2 and

retrograde instillation directly into a ureteral catheter 3 or by reflux through an indwelling ureteral stent or iatrogenically created vesicoureteral reflux 4,5. Patel described a convenient technique of outpatient instillation through a ureteral catheter placed suprapubically 6. The role of intravesical immunotherapy using bacillus Calmette-Guerin (BCG) or chemotherapy using mitomycin C for non-muscle-invasive urothelial carcinoma of the bladder has been established. However, the role of instillation therapy for upper urinary tract tumors has been equivocal, and its long-term effectiveness has not been elucidated 7. To the best of our knowledge, this is the first reported case of creation of an irrigation technique for the treatment of renal pelvic tumors in a solitary kidney after ipsilateral ureterectomy. The advantages of this technique are (1) the application of constant low pressure to minimize the risk of bacterial sepsis or systemic absorption of the agent, (2) contact of all urothelium with instillation media, (3) ability to repeat instillation therapy at low cost, and (4) safety of collecting the instillation media in the bag. It was considered that some selected multiple urothelial cancer patients might have chance to avoid bilateral nephrouretectomy using this technique.

References 1. Rouprêt M, Zigeuner R, Palou J et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011; 59: 584-594 2. Studer UE, Casanovaa G, Kraft R, Zingg EJ. Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J Urol. 1989; 142: 975-7 3. Sharpe JR, Duffy G and Chin JL. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol. 1993; 149: 457-460 4. Herr HW. Durable response of carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J Urol. 1985; 134: 531-2 5. Mukamel E, Vilkovsky E, Hadar H et al. The effect of intravesical bacillus Calmette-Guerin therapy on the upper urinary tract. J Urol. 1991; 149: 980 6. Patel A, Fuchs GJ. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol. 1998; 159: 71-5.

7. Nepple KG, Joudi FN, O'Donnell MA. Review of topical treatment of upper tract urothelial carcinoma. Adv. Urol. 2009; 472831

Figure legends Figure 1. Constant-pressure renal pelvis irrigation system Figure 2. Irrigation technique A) Make a small hole in the urine bag tube and insert a 5-Fr open-end ureteral catheter into the hole B) Keep the tip of the ureteral catheter at the end of the nephrostomy catheter C) Place the urine bag tube 20 cm above the kidney and irrigate at 100ml/h